tetradecanoylphorbol acetate and nargenicin a1

tetradecanoylphorbol acetate has been researched along with nargenicin a1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kim, SH; Kim, TS; Yoo, JC	1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and nargenicin a1

Article	Year
Nargenicin enhances 1,25-dihydroxyvitamin D(3)- and all-trans retinoic acid-induced leukemia cell differentiation via PKCbetaI/MAPK pathways. Biochemical pharmacology, 2009, Jun-01, Volume: 77, Issue:11 Topics: Calcitriol; Cell Differentiation; Cell Division; Cell Survival; Extracellular Signal-Regulated MAP Kinases; HL-60 Cells; Humans; Lactones; Mitogen-Activated Protein Kinase Kinases; Protein Kinase C; Protein Kinase C beta; Tetradecanoylphorbol Acetate; Tretinoin	2009

Article

Year

Nargenicin enhances 1,25-dihydroxyvitamin D(3)- and all-trans retinoic acid-induced leukemia cell differentiation via PKCbetaI/MAPK pathways.

Biochemical pharmacology, 2009, Jun-01, Volume: 77, Issue:11

Topics: Calcitriol; Cell Differentiation; Cell Division; Cell Survival; Extracellular Signal-Regulated MAP Kinases; HL-60 Cells; Humans; Lactones; Mitogen-Activated Protein Kinase Kinases; Protein Kinase C; Protein Kinase C beta; Tetradecanoylphorbol Acetate; Tretinoin

2009